AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The FDA has sent letters to all manufacturers of approved sedative/hypnotic drugs requesting that labeling be revised to include warnings about potential risks. Each manufacturer is sending letters to healthcare providers notifying them of new warnings …